PFIZERPharmaceuticals
Pfizer Ltd — Balance Sheet
₹4720.50
-0.37%
Pfizer Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Payables | 386.99 Cr | 340.05 Cr | 391.99 Cr | 446.48 Cr | — |
| Ordinary Shares Number | 4.57 Cr | 4.57 Cr | 4.57 Cr | 4.57 Cr | — |
| Share Issued | 4.57 Cr | 4.57 Cr | 4.57 Cr | 4.57 Cr | — |
| Total Debt | 108.40 Cr | 94.54 Cr | 134.47 Cr | 166.99 Cr | — |
| Tangible Book Value | 3.67K Cr | 3.03K Cr | 2.64K Cr | 2.24K Cr | — |
| Invested Capital | 4.22K Cr | 3.60K Cr | 3.21K Cr | 2.87K Cr | — |
| Working Capital | 2.94K Cr | 2.22K Cr | 1.87K Cr | 1.54K Cr | — |
| Net Tangible Assets | 3.67K Cr | 3.03K Cr | 2.64K Cr | 2.24K Cr | — |
| Capital Lease Obligations | 105.90 Cr | 92.04 Cr | 131.97 Cr | 164.49 Cr | — |
| Common Stock Equity | 4.22K Cr | 3.60K Cr | 3.21K Cr | 2.86K Cr | — |
| Total Capitalization | 4.22K Cr | 3.60K Cr | 3.21K Cr | 2.86K Cr | — |
| Total Equity Gross Minority Interest | 4.22K Cr | 3.60K Cr | 3.21K Cr | 2.86K Cr | — |
| Stockholders Equity | 4.22K Cr | 3.60K Cr | 3.21K Cr | 2.86K Cr | — |
| Other Equity Interest | 4.17K Cr | 3.55K Cr | 3.16K Cr | — | — |
| Retained Earnings | 2.44K Cr | 1.83K Cr | 1.46K Cr | 1.13K Cr | — |
| Additional Paid In Capital | 1.32K Cr | 1.32K Cr | 1.32K Cr | 1.32K Cr | — |
| Capital Stock | 45.75 Cr | 45.75 Cr | 45.75 Cr | 45.75 Cr | — |
| Common Stock | 45.75 Cr | 45.75 Cr | 45.75 Cr | 45.75 Cr | — |
| Total Liabilities Net Minority Interest | 693.70 Cr | 633.24 Cr | 793.43 Cr | 1.04K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 124.19 Cr | 86.68 Cr | 136.08 Cr | 183.21 Cr | — |
| Long Term Debt And Capital Lease Obligation | 67.62 Cr | 54.35 Cr | 93.32 Cr | 127.74 Cr | — |
| Long Term Capital Lease Obligation | 67.62 Cr | 54.35 Cr | 93.32 Cr | 127.74 Cr | — |
| Long Term Provisions | 56.57 Cr | 32.33 Cr | 42.76 Cr | 55.47 Cr | — |
| Current Liabilities | 569.51 Cr | 546.56 Cr | 657.35 Cr | 852.89 Cr | — |
| Other Current Liabilities | 60.96 Cr | 93.85 Cr | 70.88 Cr | 231.40 Cr | — |
| Current Deferred Taxes Liabilities | 4.20 Cr | 6.57 Cr | — | — | — |
| Current Debt And Capital Lease Obligation | 40.78 Cr | 40.19 Cr | 41.15 Cr | 39.25 Cr | — |
| Current Capital Lease Obligation | 38.28 Cr | 37.69 Cr | 38.65 Cr | 36.75 Cr | — |
| Current Debt | 2.50 Cr | 2.50 Cr | 2.50 Cr | 2.50 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 44.48 Cr | 35.67 Cr | 45.17 Cr | 50.24 Cr | — |
| Current Provisions | 27.17 Cr | 22.31 Cr | 100.52 Cr | 78.55 Cr | — |
| Other Payable | 1.97 Cr | 1.18 Cr | 1.13 Cr | 0.22 Cr | — |
| Dividends Payable | 12.46 Cr | 12.59 Cr | 13.02 Cr | 12.86 Cr | — |
| Total Tax Payable | 220.96 Cr | 160.05 Cr | 160.78 Cr | 169.46 Cr | — |
| Accounts Payable | 151.60 Cr | 166.23 Cr | 217.06 Cr | 263.94 Cr | — |
| Total Assets | 4.91K Cr | 4.23K Cr | 4.00K Cr | 3.90K Cr | — |
| Total Non Current Assets | 1.40K Cr | 1.46K Cr | 1.48K Cr | 1.50K Cr | — |
| Other Non Current Assets | 50.12 Cr | 50.09 Cr | 25.75 Cr | 25.75 Cr | — |
| Defined Pension Benefit | 5.94 Cr | 51.37 Cr | 44.21 Cr | 10.86 Cr | — |
| Non Current Prepaid Assets | 24.27 Cr | 24.78 Cr | 23.42 Cr | 47.50 Cr | — |
| Non Current Deferred Taxes Assets | 69.30 Cr | 53.94 Cr | 97.67 Cr | 46.98 Cr | — |
| Investmentin Financial Assets | 13.93 Cr | 14.28 Cr | 13.02 Cr | 0.00 | — |
| Available For Sale Securities | 13.93 Cr | 14.28 Cr | 13.02 Cr | — | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 551.80 Cr | 561.76 Cr | 571.72 Cr | 622.04 Cr | — |
| Other Intangible Assets | 24.31 Cr | 34.27 Cr | 44.23 Cr | 94.55 Cr | — |
| Goodwill | 527.49 Cr | 527.49 Cr | 527.49 Cr | 527.49 Cr | — |
| Net PPE | 179.97 Cr | 151.52 Cr | 185.78 Cr | 220.10 Cr | — |
| Accumulated Depreciation | -301.44 Cr | -259.56 Cr | -229.65 Cr | -181.14 Cr | — |
| Gross PPE | 481.41 Cr | 411.08 Cr | 415.43 Cr | 401.24 Cr | — |
| Construction In Progress | 8.15 Cr | 0.57 Cr | 8.25 Cr | 1.18 Cr | — |
| Other Properties | 171.82 Cr | 150.95 Cr | 177.53 Cr | — | 186.93 Cr |
| Machinery Furniture Equipment | 113.89 Cr | 102.19 Cr | 83.94 Cr | 76.82 Cr | — |
| Buildings And Improvements | 339.37 Cr | 288.32 Cr | 303.24 Cr | 292.47 Cr | — |
| Land And Improvements | 20.00 Cr | 20.00 Cr | 20.00 Cr | 30.77 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 3.51K Cr | 2.77K Cr | 2.53K Cr | 2.40K Cr | — |
| Other Current Assets | 0.94 Cr | 0.95 Cr | 0.50 Cr | 1.71 Cr | — |
| Assets Held For Sale Current | 0.00 | 31.75 Cr | 31.75 Cr | 35.04 Cr | — |
| Restricted Cash | 18.37 Cr | 20.11 Cr | 19.86 Cr | 23.28 Cr | — |
| Prepaid Assets | 20.98 Cr | 17.41 Cr | 23.55 Cr | 37.12 Cr | — |
| Inventory | 475.92 Cr | 433.69 Cr | 417.70 Cr | 448.90 Cr | — |
| Other Inventories | 7.81 Cr | 9.04 Cr | 10.92 Cr | 7.28 Cr | — |
| Finished Goods | 326.92 Cr | 353.75 Cr | 344.39 Cr | 397.15 Cr | — |
| Work In Process | 8.25 Cr | 6.78 Cr | 4.32 Cr | 8.04 Cr | — |
| Raw Materials | 132.94 Cr | 64.12 Cr | 58.07 Cr | 36.43 Cr | — |
| Other Receivables | 3.88 Cr | 12.35 Cr | 14.25 Cr | 42.68 Cr | — |
| Taxes Receivable | 17.06 Cr | 39.09 Cr | 26.09 Cr | 73.43 Cr | — |
| Accounts Receivable | 193.09 Cr | 187.61 Cr | 151.73 Cr | 124.27 Cr | — |
| Allowance For Doubtful Accounts Receivable | -30.61 Cr | -29.81 Cr | -29.18 Cr | -28.11 Cr | — |
| Gross Accounts Receivable | 223.70 Cr | 217.42 Cr | 180.91 Cr | 152.38 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.78K Cr | 2.03K Cr | 1.84K Cr | 1.61K Cr | — |
| Other Short Term Investments | 2.29K Cr | 1.91K Cr | 1.80K Cr | 1.55K Cr | — |
| Cash And Cash Equivalents | 495.07 Cr | 112.00 Cr | 36.60 Cr | 62.76 Cr | — |
| Cash Equivalents | 490.27 Cr | 103.07 Cr | 24.80 Cr | 26.52 Cr | — |
| Cash Financial | 4.80 Cr | 8.93 Cr | 11.80 Cr | 36.24 Cr | — |
| Investment Properties | — | — | 0.00 | 28.17 Cr | 29.56 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Pfizer Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.